Global clinical-stage biopharmaceutical company Arno Pharma listed on Nasdaq | Chenkun Family
2023-09-29
On September 29, Arno Pharma, a portfolio company invested in by Detong Capital—the sub-fund backed by the mother fund managed by Yuanhe Chenchun—was listed on NASDAQ, with the stock ticker: ANL.O.
Read
2023-09-28
On September 28, Dongrui Xikang, an investee fund of Tonghe Yucheng Investment Co., Ltd.—a sub-fund backed by the mother fund managed by Yuanhe Chencun—was listed on the Hong Kong Stock Exchange under the stock code: 9686.HK.
Read
2023-09-26
On September 26, "Tuhu Auto," a portfolio company invested in by Yuhe Chenkun's managed fund-of-funds and backed by Joy Capital, was listed on the Hong Kong Stock Exchange under the stock code: 9690.HK.
Read
2023-09-05
On September 5, Yihua Chenkun-managed fund-of-funds-backed sub-fund—Eli Lilly Asia Fund and Guoke Jiahe Investment's portfolio company, Immunocore, was listed on the Hong Kong Stock Exchange under stock code: 1541.HK.
Read
Global leader in IoT chip R&D—Telink Semiconductor debuts on the STAR Market | Chenkun Family
2023-08-25
On August 25, "Tailing Microelectronics," a portfolio company invested in by Qingyu Fund—a sub-fund backed by the mother fund managed by Yuanhe Chencun—was listed on the STAR Market of the Shanghai Stock Exchange, with stock code: 688591.
Read
China's Pet Food Industry Leader—Guabao Foods Debuts on the ChiNext Board | Chenkun Family
2023-08-16
On August 16, "Guai Bao Foods," a portfolio company invested in by Junlian Capital—the sub-fund backed by the mother fund managed by Yuanhe Chencun—was listed on the ChiNext Board of the Shenzhen Stock Exchange, with stock code: 301498.
ReadSuzhou:+86-0512-66969722
Beijing:+86-010-65000132
Scan QR code